Studies have suggested that metformin targets the YAP1-TEAD4 complex via AMPKα, regulating the expression of CCNE1/2 (Cyclin E) in bladder cancer cells, inducing cell-cycle arrest and ultimately affecting cell growth.93 The gene discussed is CCNE1; the disease is urinary bladder cancer.